ACEIs and AT1R (Angiotensin type 1 receptor) inhibitors are commonly used RAAS system inhibitors that have been widely used in the treatment of hypertension, diabetic nephropathy, and congestive heart failure.3 This evidence concerns the gene AGTR1 and diabetic kidney disease.